2025-03-28 18:55:33
Latest Post
Maithan A1loys Limited purchases 1.99 lakh shares of NSE
Lancor Holdings Ltd updates on new projects
Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
Aerolloy Technologies secures major order from Safran Aircraft Engines for LEAP Engine Cast Components
Stock Report
IEL Ltd Q4 FY2023-24 net profit at Rs. 13.57 lakhs
Posted On : 2024-04-22 22:13:08( TIMEZONE : IST )
has reported Standalone financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 9.1237 crores during the period ended March 31, 2024 as compared to Rs. 5.4919 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 0.1357 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 0.1109 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.041 for the period ended March 31, 2024 as compared to Rs. 0.033 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 9.1237 crs | ₹5.4919 crs |  66.13% |
| Net Profit | ₹0.1357 crs | ₹0.1109 crs | 22.36% |
| EPS | ₹0.041 | ₹0.033 | 24.24% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 9.1237 crores during the period ended March 31, 2024 as compared to Rs.1.0601 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.1357 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.-0.0420 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.041 for the period ended March 31, 2024 as compared to Rs.-0.013 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 9.1237 crs | ₹1.0601 crs | 760.65% |
| Net Profit | ₹0.1357 crs | ₹-0.0420 crs | 423.10% |
| EPS | ₹0.041 | ₹-0.013 | 415.38% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.17.2621 crores during the Financial Year ended March 31, 2024 as compared to Rs.11.0986 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.2568 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.2.3663 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.0.077 for the Financial Year ended March 31, 2024 as compared to Rs.0.709 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹17.2621 crs | ₹11.0986 crs | 55.53% |
| Net Profit | ₹0.2568 crs | ₹2.3663 crs |  -89.15% |
| EPS | ₹0.077 | ₹0.709 | -89.14% |
